期刊文献+

肝脏转运体表达和功能的变化对肝疾病的影响 被引量:3

Effect of altered expression and function of hepatic transporters on liver disease
下载PDF
导出
摘要 转运体是药物吸收、分布、代谢和排泄的重要决定因素,在肝脏表达尤为广泛.肝脏转运体可以摄取大多数内源性物质、营养物质和外源性物质进入肝脏,在肝脏内经过一系列的代谢转化,最终将其外排入胆汁并由胆汁排到肝外.越来越多的证据表明肝脏疾病状态下转运体的表达和功能会发生改变,影响药物在体内的处置过程,进而增加药物相互作用的可能性,同时加大了疾病药物治疗的难度.本文从肝脏摄取型和外排型转运体两方面出发,针对肝脏转运体表达和功能的变化对肝疾病的影响作一综述. Hepatic transporters are extensively expressed in the human body, especially in the liver. They are important determinants for drug absorption, distribution, metabolism and excretion. Most of endogenous substances, nutrients and exogenous substances can be transported into hepatocytes by hepatic uptake transporters. After metabolism, their metabolic products are excreted into bile. All the clinical relevance of hepatic transporters in drug disposition depends on their localization on the membrane of hepatocytes. There has been growing evidence regarding the importance of liver disease status on alterations in hepatic transporter proteins, which can increase the difficulty of drug therapy by influencing the process of drug disposition. This review focuses on uptake and efflux transporter proteins in the liver and summarizes the effect of alterations of hepatic transporter expression and function on liver disease.
出处 《世界华人消化杂志》 CAS 2017年第16期1427-1437,共11页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 Nos.81302838 81473280~~
关键词 转运体 表达变化 功能变化 肝疾病 Transporter Alteration of expression Alteration of function Liver disease
  • 相关文献

参考文献1

二级参考文献29

  • 1Shitara Y, Horie T, Sugiyama Y. Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 2006; 27: 425-446.
  • 2Zollner G, Fickert P, Silbert D, Fuchsbichler A, Marschall HU, Zatloukal K, Denk H, Trauner M. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 2003; 38: 717-727.
  • 3Kanda D, Takagi H, Kawahara Y, Yata Y, Takakusagi T, Hatanaka T, Yoshinaga T, Iesaki K, Kashiwabara K, Higuchi T, Mori M, Hirota T, Higuchi S, Ieiri I. Novel large-scale deletion (whole exon 7) in the ABCC2 gene in a patient with the Dubin-Johnson syndrome. Drug Metab Pharmacokinet 2009; 24: 464-468.
  • 4Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci 2004; 61: 682-699.
  • 5Alrefai WA, Gill RK. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 2007; 24: 1803-1823.
  • 6Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 2006; 34: 1756-1763.
  • 7Sai Y, Tsuji A. Transporter-mediated drug delivery: recent progress and experimental approaches. Drug Discov Today 2004; 9: 712-720.
  • 8Kouzuki H, Suzuki H, Stieger B, Meier PJ, Sugiyama Y. Characterization of the transport properties of organic anion transporting polypeptide 1 (oatp1) and Na(+)/taurocholate cotransporting polypeptide (Ntcp): comparative studies on the inhibitory effect of their possible substrates in hepatocytes and cDNA-transfected COS-7 cells. J Pharmacol Exp Ther 2000; 292: 505-511.
  • 9Leonhardt M, Keiser M, Oswald S, Kühn J, Jia J, Grube M, Kroemer HK, Siegmund W, Weitschies W. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters. Drug Metab Dispos 2010; 38: 1024-1028.
  • 10Agarwal S, Pal D, Mitra AK. Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor. Int J Pharm 2007; 339: 139-147.

共引文献12

同被引文献20

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部